Stocks Health care CGEN
NASDAQ · Health careCompugen Ltd (CGEN)
Compugen Ltd reported revenue of $72.8M in fiscal 2025, up 161.1% from a year earlier. Net income was $35.3M, a net margin of 48.6%. Operating cash flow minus capital spending left $31.3M of free cash flow in fiscal 2025. At December 31, 2025 it held $90.6M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 2, 2026.
What Compugen Ltd does
Compugen Ltd is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker CGEN.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $72.8M | $35.3M | $0.38 | $31.3M |
| 2024 | $27.9M | -$14.2M | -$0.16 | $49.5M |
| 2023 | $33.5M | -$18.8M | -$0.21 | -$36.1M |
| 2022 | $7.5M | -$33.7M | -$0.39 | -$34.6M |
| 2021 | $6M | -$34.2M | -$0.41 | -$23M |
| 2020 | $2M | -$29.7M | -$0.37 | -$28.5M |
Latest SEC filings
What Compugen Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 10, 2026
- August 3, 2026
- August 3, 2026
- May 18, 2026Form F-3 filing F-3
- May 18, 2026
- March 2, 2026Annual report (foreign issuer) 20-F · period to December 31, 2025
- March 2, 2026
- February 12, 2026
- December 17, 2025
- November 10, 2025
Questions about CGEN
What does Compugen Ltd do?
Compugen Ltd is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker CGEN.
Is Compugen Ltd profitable?
Yes. In fiscal 2025 it reported net income of $35.3M on revenue of $72.8M, a net margin of 48.6%.
How much revenue does Compugen Ltd make?
In fiscal 2025 Compugen Ltd reported revenue of $72.8M. That is 161.1% more than a year earlier.
When did Compugen Ltd last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 2, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 10, 2026.
Similar companies
Follow CGEN
Get an email when Compugen Ltd files with the SEC: results, executive changes, material agreements and annual reports.
Follow CGEN: get an email when it filesWhere the numbers come from
Financial figures are the values Compugen Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.